CN Patent

CN121449721A — 经修饰的gip肽类似物

Assigned to Individual · Expires 2026-02-03 · 0y expired

What this patent protects

公开了葡萄糖依赖性促胰岛素肽(GIP)衍生的肽类似物，所述肽类似物是GIP受体的拮抗剂。这些GIP肽类似物通过包含一个或多个单独的氨基酸取代而被修饰并且是用/不用接头缀合脂肪酸的，从而具有改善的拮抗活性和改善的药代动力学概况。

USPTO Abstract

公开了葡萄糖依赖性促胰岛素肽(GIP)衍生的肽类似物，所述肽类似物是GIP受体的拮抗剂。这些GIP肽类似物通过包含一个或多个单独的氨基酸取代而被修饰并且是用/不用接头缀合脂肪酸的，从而具有改善的拮抗活性和改善的药代动力学概况。

Drugs covered by this patent

Patent Metadata

Patent number
CN121449721A
Jurisdiction
CN
Classification
—
Expires
2026-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.